Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “outperform” rating reiterated by William Blair in a research report issued on Tuesday, RTT News reports. Several other brokerages also recently commented on JANX. Wedbush upped their price objective on Janux Therapeutics from $24.00 to $53.00 and gave the company an “outperform” rating in a […]
Janux Therapeutics (NASDAQ:JANX – Get Free Report) and PaxMedica (NASDAQ:PXMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Profitability This table compares Janux Therapeutics and PaxMedica’s […]
Janux Therapeutics (NASDAQ:JANX – Get Free Report) and PaxMedica (NASDAQ:PXMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk Janux Therapeutics has a beta […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) shares rose 5.1% during mid-day trading on Thursday . The stock traded as high as $9.85 and last traded at $9.50. Approximately 65,361 shares were traded during mid-day trading, a decline of 25% from the average daily volume of 86,818 shares. The stock had previously closed at […]
By Josh Beckerman Janux Therapeutics shares were up 12% after existing investor Avalon Ventures reported the purchase of 849,854 shares at $5.87 in a filing.